{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:51:16Z","timestamp":1784616676602,"version":"3.55.0"},"reference-count":26,"publisher":"Impact Journals, LLC","issue":"55","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,7,17]]},"DOI":"10.18632\/oncotarget.25769","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T15:25:36Z","timestamp":1531841136000},"page":"30649-30660","source":"Crossref","is-referenced-by-count":38,"title":["Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers"],"prefix":"10.18632","volume":"9","author":[{"given":"Gloria H.J.","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei Yi","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.H.","family":"Low","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, National University Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai Loong","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.W.","family":"Ow","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.P.","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"},{"name":"Cancer Science Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Wan","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Eng","family":"Lim","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Chin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore"},{"name":"Cancer Science Institute, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,7,17]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.47102\/annals-acadmedsg.V44N10p492","article-title":"Singapore cancer network (SCAN) guidelines for referral for genetic evaluation of common hereditary cancer syndromes","volume":"44","author":"Tan","year":"2015","journal-title":"Ann Acad Med Singapore"},{"key":"2","unstructured":"NCCN. Genetic\/Familial High-Risk Assessment: Breast and Ovarian. 2017."},{"key":"3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10689-014-9741-4","article-title":"Cancer genetic testing panels for inherited cancer susceptibility: the clinical experience of a large adult genetics practice","volume":"13","author":"Hulick","year":"2014","journal-title":"Fam Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"e0185615","DOI":"10.1371\/journal.pone.0185615","article-title":"The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: from BRCA1\/2 to multi-gene panels","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer","volume":"34","author":"Garber","year":"2016","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1089\/gtmb.2011.0268","article-title":"Discrepancy between initial high expression of interest in clinical cancer genetic testing and actual low uptake in an Asian population","volume":"16","author":"Lee","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"7","unstructured":"Ling, Li, Min, Eric Lee, Hsiang, Guat, Kelly, Har, Nurhidayah, Yap, Ching. Singapore Cancer Registry Annual Registry Report 2015 National Registry of Diseases Office (NRDO). 2017."},{"key":"8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/ejhg.2014.157","article-title":"A clinical and genetic analysis of multiple primary cancer referrals to genetics services","volume":"23","author":"Maher","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ygyno.2015.01.537","article-title":"Hereditary predisposition to ovarian cancer, looking beyond BRCA1\/BRCA2","volume":"137","author":"Monk","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/bcr2832","article-title":"Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1\/2-founder mutation-negative breast and\/or ovarian cancer individuals","volume":"13","author":"Sallinen","year":"2011","journal-title":"Breast Cancer Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","article-title":"Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer","volume":"3","author":"Pesaran","year":"2017","journal-title":"JAMA Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.30428","article-title":"Gene panel sequencing in familial breast\/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1\/2","volume":"140","author":"Reis","year":"2017","journal-title":"Int J Cancer"},{"key":"13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-016-4034-2","article-title":"Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer","volume":"161","author":"Kim","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"14","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1002\/ijc.25870","article-title":"Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer","volume":"129","author":"Haile","year":"2011","journal-title":"Int J Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Robson","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"16","article-title":"Genetic\/Familial High-Risk Assessment","author":"NCCN","year":"2017","journal-title":"Colorectal Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"18","author":"Pineda-Alvarez","year":"2016","journal-title":"Genet Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-genom-091416-035305","article-title":"Application of Panel-Based Tests for Inherited Risk of Cancer","volume":"18","author":"Nathanson","year":"2017","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cge.12315","article-title":"A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes","volume":"86","author":"Burbidge","year":"2014","journal-title":"Clin Genet"},{"key":"20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1056\/NEJM199705153362002","article-title":"BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer","volume":"336","author":"Weber","year":"1997","journal-title":"N Engl J Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2350-9-116","article-title":"Selecting a BRCA risk assessment model for use in a familial cancer clinic","volume":"9","author":"Bordeleau","year":"2008","journal-title":"BMC Med Genet"},{"key":"22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/j.gastro.2010.08.021","article-title":"The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history","volume":"140","author":"Syngal","year":"2011","journal-title":"Gastroenterology"},{"key":"23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Lynch","year":"1999","journal-title":"Gastroenterology"},{"key":"24","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":"A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines","volume":"89","author":"Srivastava","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1200\/JCO.2009.22.7967","article-title":"2009 version of the Chompret criteria for Li Fraumeni syndrome","volume":"27","author":"Fr\u00e9bourg","year":"2009","journal-title":"J Clin Oncol"},{"key":"26","first-page":"101","article-title":"Germline mutations in the TP53 gene","volume":"25","author":"Eeles","year":"1995","journal-title":"Cancer Surv"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T19:34:50Z","timestamp":1661628890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,17]]},"references-count":26,"journal-issue":{"issue":"55","published-print":{"date-parts":[[2018,7,17]]}},"alternative-id":["25769","30093976"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25769","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,17]]}}}